Search Results 441-450 of 12559 for alp

  1. Financial Fact Sheet

    The Financial Fact Sheet is designed to collect program financial data and provide applicants with transparent information on the true costs of residency ...

  2. EP study - Doctors & Departments - Mayo Clinic

    An electrophysiology study can show the cause of irregular heart rhythms and guide treatment. Know when it's done and the risks.

  3. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Serum alkaline phosphatase ≤ 3x ULN (upper limit of normal)in the absence of liver or bone metastases or ≤5 ULN(in patients with documented bone or liver ...

  4. A Study to Evaluate 9-ING-41 As a Single Agent or in Combination with Ruxolitinib in Myelofibrosis Patients - Mayo Clinic

    Transaminases (AST/ALT) and alkaline phosphatase ≤ 3 x ULN;; Bilirubin ≤ 1.5 x ULN (unless patient has Gilbert's Syndrome);; Serum amylase and lipase ≤ 1.5 ...

  5. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) - Mayo Clinic

    Alkaline phosphatase ≤ 2.5 x ULN; Serum creatinine within upper limits of normal or calculated clearance ≥50 mL/min/1.73 m2. If using creatinine clearance ...

  6. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    Alkaline phosphatase ≤ 1.5 times IULN; Serum creatinine level ≤ IULN; Fasting cholesterol ≤ 300 mg/dL and triglycerides ≤ 2.5 times IULN; patients may be ...

  7. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    AST, ALT, and alkaline phosphatase ≤ 2.5 x the upper limit of normal (ULN); Serum bilirubin ≤ 1.5 x ULN; Patients with known Gilbert disease who have serum ...

  8. Neurology - Clinical trials

    The purpose of this study is to study the length of the QTc interval in patients receiving the standard of care dose of intravenous droperidol for headache ...

  9. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    Alkaline phosphatase =< 2.5 x ULN; International normalized ratio (INR) < 1.5 x ULN for institution unless patient is on planned therapy with anticoagulants ...

  10. Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma - Mayo Clinic

    Alkaline Phosphatase (Alk Phos) ≤ 1.5 x upper limit of normal (ULN);; Total and Direct Bilirubin ≤ 1.5 × (ULN);; Aspartate aminotransferase (AST) ≤ 1.5 ...